Loading clinical trials...
Loading clinical trials...
An Open-label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
Conditions
Interventions
levothyroxine sodium capsule
Proton pump inhibitor (PPI)
+1 more
Locations
9
United States
California Head and Neck Specialists
La Jolla, California, United States
Coastal Metabolic Research Centre
Ventura, California, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
MedStar Union Memorial Hospital
Baltimore, Maryland, United States
NYC Health + Hospitals/ Queens
New York, New York, United States
Diabetes & Endocrinology Consultants, PC
Morehead City, North Carolina, United States
Start Date
July 30, 2018
Primary Completion Date
June 15, 2020
Completion Date
June 15, 2020
Last Updated
April 5, 2022
Lead Sponsor
IBSA Institut Biochimique SA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions